InVivo Biosystems Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 45

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $3M

  • Investors
  • 17

InVivo Biosystems General Information

Description

Developer of a genome editing platform designed to accelerate deep in-vivo insights into human biology. The company's platform creates custom genome-edited C. elegans and zebrafish models to enhance aging, developmental, and disease studies, enabling researchers to perform mutant phenotyping, drug screening, and toxicological assessment.

Contact Information

Formerly Known As
NemaMetrics, NemaMetrix
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1505 Westec Drive
  • Eugene, OR 97402
  • United States
+1 (844)
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 1505 Westec Drive
  • Eugene, OR 97402
  • United States
+1 (844)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

InVivo Biosystems Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC 03-Jan-2024 $3M Completed Generating Revenue
10. Grant 10-Dec-2020 Completed Generating Revenue
9. Grant 24-Apr-2020 Completed Generating Revenue
8. Debt - PPP 15-Apr-2020 Completed Generating Revenue
7. Later Stage VC 27-Feb-2019 Completed Generating Revenue
6. Later Stage VC (Series A) 08-Mar-2017 Completed Generating Revenue
5. Angel (individual) 28-Aug-2015 Completed Startup
4. Accelerator/Incubator 04-Feb-2015 Completed Startup
3. Grant 01-Feb-2014 $346K Completed Startup
2. Accelerator/Incubator 01-Jan-2014 Completed Startup
To view InVivo Biosystems’s complete valuation and funding history, request access »

InVivo Biosystems Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view InVivo Biosystems’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

InVivo Biosystems Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a genome editing platform designed to accelerate deep in-vivo insights into human biology. The company's pl
Discovery Tools (Healthcare)
Eugene, OR
45 As of 2025

Saint Louis, MO
 

San Jose, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

InVivo Biosystems Competitors (16)

One of InVivo Biosystems’s 16 competitors is Mayflower Bioscience, a Formerly Accelerator/Incubator backed company based in Saint Louis, MO.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Mayflower Bioscience Formerly Accelerator/Incubator backed Saint Louis, MO
Molecular Devices Corporate Backed or Acquired San Jose, CA
BioLegend Formerly Accelerator/Incubator backed San Diego, CA
Premas Biotech Venture Capital-Backed Gurugram, India
Sygnature Discovery Private Equity-Backed Nottingham, United Kingdom
You’re viewing 5 of 16 competitors. Get the full list »

InVivo Biosystems Patents

InVivo Biosystems Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4735885-A1 Methods for identifying compounds affecting human health Pending 30-Jun-2023
WO-2025007151-A1 Methods for identifying compounds affecting human health Inactive 30-Jun-2023
CA-3162691-A1 Model organisms humanized for drug discovery and screening Pending 21-Dec-2019
EP-4078179-A1 Model organisms humanized for drug discovery and screening Pending 21-Dec-2019
EP-4078179-A4 Model organisms humanized for drug discovery and screening Pending 21-Dec-2019 A01K67/0275
To view InVivo Biosystems’s complete patent history, request access »

InVivo Biosystems Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

InVivo Biosystems Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ideaship Venture Capital Minority
Launch Oregon Corporate Venture Capital Minority
National Institutes of Health Government
The National Human Genome Research Institute Government
Oregon Nano and Micro technology Institute (ONAMI) Corporation Minority
You’re viewing 5 of 17 investors. Get the full list »

InVivo Biosystems Acquisitions (1)

InVivo Biosystems’s most recent deal was a Merger/Acquisition with Knudra Transgenics. The deal was made on 14-Nov-2017.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Knudra Transgenics 14-Nov-2017 Merger/Acquisition Biotechnology
To view InVivo Biosystems’s complete acquisitions history, request access »

InVivo Biosystems FAQs

  • When was InVivo Biosystems founded?

    InVivo Biosystems was founded in 2010.

  • Where is InVivo Biosystems headquartered?

    InVivo Biosystems is headquartered in Eugene, OR.

  • What is the size of InVivo Biosystems?

    InVivo Biosystems has 45 total employees.

  • What industry is InVivo Biosystems in?

    InVivo Biosystems’s primary industry is Discovery Tools (Healthcare).

  • Is InVivo Biosystems a private or public company?

    InVivo Biosystems is a Private company.

  • What is InVivo Biosystems’s current revenue?

    The current revenue for InVivo Biosystems is .

  • How much funding has InVivo Biosystems raised over time?

    InVivo Biosystems has raised $12.2M.

  • Who are InVivo Biosystems’s investors?

    Ideaship, Launch Oregon, National Institutes of Health, The National Human Genome Research Institute, and Oregon Nano and Micro technology Institute (ONAMI) are 5 of 17 investors who have invested in InVivo Biosystems.

  • Who are InVivo Biosystems’s competitors?

    Mayflower Bioscience, Molecular Devices, BioLegend, Premas Biotech, and Sygnature Discovery are some of the 16 competitors of InVivo Biosystems.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process